Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-07-15

Clinical Trial Update: Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating different dosing regimens of fexinidazole for adult patients with Chagas disease. The sponsor is Drugs for Neglected…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Chagas Disease, Trypanosomiasis, South American | Phase 2 | Status: UNKNOWN